glp 1 lean mass loss Balancing weight and muscle in GLP1 receptor agonist therapy GLP-1 agonists and changes in

Description

Clinical trials have demonstrated significant benefits of prescription GLP-1 agonists

From clinical studies and real-world experience, general patterns often look like this: First 48 weeks: Appetite starts to calm down

In those cases, the issue is often not medical necessity but the fact that the employer or plan simply did not elect to cover the medication in the first place. Prior authorization and coverage requirements Even when a GLP-1 is covered, most insurance plans require prior authorization, which consists of a set of clinical questions your doctor must answer to justify why you qualify

Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor